![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PHTF1 |
Gene summary for PHTF1 |
![]() |
Gene information | Species | Human | Gene symbol | PHTF1 | Gene ID | 10745 |
Gene name | putative homeodomain transcription factor 1 | |
Gene Alias | PHTF | |
Cytomap | 1p13.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q9UMS5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10745 | PHTF1 | LZE7T | Human | Esophagus | ESCC | 1.47e-06 | 4.03e-01 | 0.0667 |
10745 | PHTF1 | P1T-E | Human | Esophagus | ESCC | 1.04e-02 | 1.53e-01 | 0.0875 |
10745 | PHTF1 | P2T-E | Human | Esophagus | ESCC | 6.89e-35 | 4.78e-01 | 0.1177 |
10745 | PHTF1 | P4T-E | Human | Esophagus | ESCC | 1.46e-13 | 3.57e-01 | 0.1323 |
10745 | PHTF1 | P5T-E | Human | Esophagus | ESCC | 7.31e-07 | 1.18e-01 | 0.1327 |
10745 | PHTF1 | P8T-E | Human | Esophagus | ESCC | 1.27e-14 | 2.41e-01 | 0.0889 |
10745 | PHTF1 | P9T-E | Human | Esophagus | ESCC | 4.65e-16 | 3.55e-01 | 0.1131 |
10745 | PHTF1 | P10T-E | Human | Esophagus | ESCC | 4.45e-19 | 3.36e-01 | 0.116 |
10745 | PHTF1 | P11T-E | Human | Esophagus | ESCC | 2.86e-08 | 3.10e-01 | 0.1426 |
10745 | PHTF1 | P12T-E | Human | Esophagus | ESCC | 3.87e-09 | 1.46e-01 | 0.1122 |
10745 | PHTF1 | P16T-E | Human | Esophagus | ESCC | 4.44e-08 | 1.54e-01 | 0.1153 |
10745 | PHTF1 | P20T-E | Human | Esophagus | ESCC | 5.37e-05 | 8.93e-02 | 0.1124 |
10745 | PHTF1 | P21T-E | Human | Esophagus | ESCC | 8.84e-05 | 1.09e-01 | 0.1617 |
10745 | PHTF1 | P22T-E | Human | Esophagus | ESCC | 1.37e-13 | 2.60e-01 | 0.1236 |
10745 | PHTF1 | P23T-E | Human | Esophagus | ESCC | 6.04e-03 | 1.37e-01 | 0.108 |
10745 | PHTF1 | P24T-E | Human | Esophagus | ESCC | 4.74e-07 | 9.72e-02 | 0.1287 |
10745 | PHTF1 | P26T-E | Human | Esophagus | ESCC | 8.04e-06 | 9.97e-02 | 0.1276 |
10745 | PHTF1 | P27T-E | Human | Esophagus | ESCC | 2.02e-06 | 1.36e-01 | 0.1055 |
10745 | PHTF1 | P28T-E | Human | Esophagus | ESCC | 1.33e-14 | 1.82e-01 | 0.1149 |
10745 | PHTF1 | P30T-E | Human | Esophagus | ESCC | 3.78e-06 | 2.82e-01 | 0.137 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PHTF1 | SNV | Missense_Mutation | c.29N>G | p.Ser10Trp | p.S10W | Q9UMS5 | protein_coding | deleterious(0.01) | probably_damaging(0.963) | TCGA-A2-A0EQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
PHTF1 | SNV | Missense_Mutation | c.1677N>A | p.Phe559Leu | p.F559L | Q9UMS5 | protein_coding | tolerated(1) | benign(0.065) | TCGA-A8-A079-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD | |
PHTF1 | insertion | Nonsense_Mutation | novel | c.1060_1061insTATAAGTCAGTGAATCAATCAAGTCAGTGATTCAAATCAATAAAT | p.Gly354delinsValTerValSerGluSerIleLysSerValIleGlnIleAsnLysCys | p.G354delinsV*VSESIKSVIQINKC | Q9UMS5 | protein_coding | TCGA-AO-A03T-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | ||
PHTF1 | insertion | Frame_Shift_Ins | rs750248180 | c.1637_1638insT | p.Met547HisfsTer10 | p.M547Hfs*10 | Q9UMS5 | protein_coding | TCGA-D8-A1Y1-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | PD | ||
PHTF1 | SNV | Missense_Mutation | c.953N>G | p.Ser318Cys | p.S318C | Q9UMS5 | protein_coding | deleterious(0.01) | benign(0.219) | TCGA-EK-A3GJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PHTF1 | SNV | Missense_Mutation | c.702N>C | p.Lys234Asn | p.K234N | Q9UMS5 | protein_coding | tolerated(0.13) | possibly_damaging(0.704) | TCGA-EK-A3GK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PHTF1 | SNV | Missense_Mutation | c.96G>C | p.Gln32His | p.Q32H | Q9UMS5 | protein_coding | deleterious(0.01) | possibly_damaging(0.837) | TCGA-MU-A51Y-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
PHTF1 | SNV | Missense_Mutation | novel | c.1648G>A | p.Val550Met | p.V550M | Q9UMS5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-VS-A9U6-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
PHTF1 | SNV | Missense_Mutation | novel | c.632N>C | p.Arg211Thr | p.R211T | Q9UMS5 | protein_coding | deleterious(0.05) | benign(0.069) | TCGA-VS-A9UZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
PHTF1 | SNV | Missense_Mutation | c.1476N>G | p.Phe492Leu | p.F492L | Q9UMS5 | protein_coding | tolerated(0.21) | benign(0.015) | TCGA-A6-4105-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |